optic neuritis glp 1 Investigating the Link Between Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Non-arteritic Ischemic Neuropathy: A Case Report of Semaglutide-Induced Optic Neuropathy Ozempic Blindness: Should You Worry?

Altimmune, Inc.(NASDAQ: ALT) announced plans to relocate its corporate headquarters from Gaithersburg, Maryland, to Morristown, New Jersey, later this year

Some studies, though not conclusive, predict that tirzepatide may in fact be more potent than GLP-1 RAs at reducing weight

Case reports document perioperative aspiration in semaglutide users, including episodes of hypoxemia and reintubation despite guideline-concordant fasting

Recently, the GLP-1 RA semaglutide was reported to reduce cardiovascular events in ASCVD patients with overweight or obesity even in the absence of diabetes mellitus

However, there was no significant difference in adverse CVEs or all-cause mortality when compared with those taking SGLT2 inhibitors

Follow Reza Hosseini Ghomi, MD, MSE for brain health that cuts through the hype Repost if you think more people should know about this Are you on a GLP-1